JPS5813600A - ２β，１６β−ジ−アミノ５α−アンドロスタン類の新規なモノ−及びビス第四級アンモニウム誘導体及びこれらを含有する医薬製剤 - Google Patents

２β，１６β−ジ−アミノ５α−アンドロスタン類の新規なモノ−及びビス第四級アンモニウム誘導体及びこれらを含有する医薬製剤

Info

Publication number
JPS5813600A
JPS5813600A JP57101942A JP10194282A JPS5813600A JP S5813600 A JPS5813600 A JP S5813600A JP 57101942 A JP57101942 A JP 57101942A JP 10194282 A JP10194282 A JP 10194282A JP S5813600 A JPS5813600 A JP S5813600A
Authority
JP
Japan
Prior art keywords
group
compound
acid
methyl
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57101942A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0249320B2 (cg-RX-API-DMAC7.html
Inventor
イアン・クレイグ・カ−リル
デヴイツド・サミユエル・サヴイツジ
ト−マス・スレイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of JPS5813600A publication Critical patent/JPS5813600A/ja
Publication of JPH0249320B2 publication Critical patent/JPH0249320B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP57101942A 1981-06-15 1982-06-14 ２β，１６β−ジ−アミノ５α−アンドロスタン類の新規なモノ−及びビス第四級アンモニウム誘導体及びこれらを含有する医薬製剤 Granted JPS5813600A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8118365 1981-06-15
GB8118365 1981-06-15

Publications (2)

Publication Number Publication Date
JPS5813600A true JPS5813600A (ja) 1983-01-26
JPH0249320B2 JPH0249320B2 (cg-RX-API-DMAC7.html) 1990-10-29

Family

ID=10522526

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57101942A Granted JPS5813600A (ja) 1981-06-15 1982-06-14 ２β，１６β−ジ−アミノ５α−アンドロスタン類の新規なモノ−及びビス第四級アンモニウム誘導体及びこれらを含有する医薬製剤

Country Status (11)

Country Link
US (1) US4447425A (cg-RX-API-DMAC7.html)
EP (1) EP0067480B1 (cg-RX-API-DMAC7.html)
JP (1) JPS5813600A (cg-RX-API-DMAC7.html)
AU (1) AU551427B2 (cg-RX-API-DMAC7.html)
CA (1) CA1186681A (cg-RX-API-DMAC7.html)
DE (1) DE3261364D1 (cg-RX-API-DMAC7.html)
DK (1) DK268382A (cg-RX-API-DMAC7.html)
ES (1) ES8308889A1 (cg-RX-API-DMAC7.html)
FI (1) FI72731C (cg-RX-API-DMAC7.html)
HU (1) HU186074B (cg-RX-API-DMAC7.html)
IE (1) IE53463B1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804576A (en) * 1983-08-02 1998-09-08 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17-ones and 5-androstan-17-ones
US5656621A (en) * 1983-08-02 1997-08-12 Research Corporation Tech., Inc. Steroids useful as anti-cancer and anti-obesity agents
US5714481A (en) * 1983-08-02 1998-02-03 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17 ones and 5-androstan-17-ones
JPS6069096A (ja) * 1983-08-02 1985-04-19 リサ−チ・コ−ポレイシヨン 新規ステロイド
GB8708886D0 (en) * 1987-04-14 1987-05-20 Akzo Nv 2beta-morpholino-androstane derivatives
GB8804579D0 (en) * 1988-02-26 1988-03-30 Akzo Nv Novel 16-homo-piperidino-androstane derivatives & processes for their preparation
DE4232656C2 (de) * 1992-09-29 1995-01-12 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17-furyl-3ß-derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutischen Zusammensetzungen
CZ300694A3 (en) * 1993-12-02 1996-05-15 Akzo Nobel Nv Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
IT1277700B1 (it) * 1995-12-22 1997-11-11 Poli Ind Chimica Spa Processo di preparazione di 2-beta, 16-beta-diamino 3-alfa, 17-beta- diacilossi 5-alfaandrostani, bloccanti neuromuscolari a struttura
US7642246B2 (en) * 2005-09-13 2010-01-05 Sicor Inc. Pure rocuronium bromide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138605A (en) * 1965-02-19 1969-01-01 Organon Labor Ltd Improvements in or relating to new 2-ß,16-ß-diamino-androstanes
GB1454749A (en) * 1972-11-29 1976-11-03 Akzo Nv 2beta, 16beta-diamino-androstanes and their preparation
EP0008824B1 (en) * 1978-09-05 1982-04-28 Akzo N.V. Acid addition salts of 16-beta-monoquaternary ammonium derivatives of 2-beta, 16-beta-bis-piperidino-androstanes and pharmaceutical preparations containing same
IE50675B1 (en) * 1979-12-12 1986-06-11 Akzo Nv Bis-and mono-quaternary ammonium derivatives of 2beta,16beta-dipiperidino-5alpha-androstanes,processes for their preparation and pharmaceutical preparations

Also Published As

Publication number Publication date
US4447425A (en) 1984-05-08
FI72731C (fi) 1987-07-10
AU8483882A (en) 1982-12-23
FI822131A0 (fi) 1982-06-14
IE53463B1 (en) 1988-11-23
JPH0249320B2 (cg-RX-API-DMAC7.html) 1990-10-29
EP0067480A1 (en) 1982-12-22
EP0067480B1 (en) 1984-11-28
HU186074B (en) 1985-05-28
ES513088A0 (es) 1983-08-16
AU551427B2 (en) 1986-05-01
ES8308889A1 (es) 1983-08-16
FI72731B (fi) 1987-03-31
DK268382A (da) 1982-12-16
CA1186681A (en) 1985-05-07
DE3261364D1 (en) 1985-01-10
IE821365L (en) 1982-12-15

Similar Documents

Publication Publication Date Title
JPS5813600A (ja) ２β，１６β−ジ−アミノ５α−アンドロスタン類の新規なモノ−及びビス第四級アンモニウム誘導体及びこれらを含有する医薬製剤
US3318926A (en) 7alpha-methyl-16alpha-hydroxy-estrones
JP2593685B2 (ja) Ｃ１７−２０リアーゼ阻害剤として有用な１７β‐（シクロプロピロキシ）アンドロスト‐５‐エン‐３β‐オール及び関連化合物類
EP0051762B1 (de) 11-Methylen-delta-15-Steroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
US2918463A (en) 17-carboxyalkylated 17-hydroxy-19-norandrosten-3-ones
DE2546062C3 (cg-RX-API-DMAC7.html)
JPH026360B2 (cg-RX-API-DMAC7.html)
DE1793618C3 (de) 07.03.63 USA 263441 Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden der Androstanreihe
EP0005758B1 (de) Verfahren zum Aufbau der Hydroxyacetyl-Seitenkette von Steroiden des Pregnan-Typs, neue 21-Hydroxy-20-oxo-17alpha-pregnan-Verbindungen und pharmazeutische Präparate enthaltend dieselben
US3133913A (en) 17alpha-methyl steroids and process to make same
DE2706860A1 (de) Neue d-homosteroide
EP0044495B1 (de) 16-Beta-Ethylsteroide, diese enthaltende Präparate und Verfahren zu ihrer Herstellung
US3277121A (en) Conversion of delta11-steroids to 11-oxygenated steroids
CA1113452A (en) Water-soluble corticoids
US2996523A (en) Method for the production of 6-methylsteroid derivatives
US3053735A (en) Enol ethers of 6-chloro substituted delta-3-ketones of the androstane series
DE1087598B (de) Verfahren zur Herstellung von 21-Amino-corticosteroiden
AT253142B (de) Verfahren zur Herstellung von neuen schwefelhaltigen Androstanderivaten
DE3426771C2 (de) 13alpha-Methylgonane, deren Herstellung und Verwendung
DE2817081A1 (de) D-homosteroide
US3246017A (en) 3alpha-aminoandrost-5-ene 17beta-carboxyalic acid and derivatives thereof
EP0092174A1 (de) 11Beta-Chlor-Delta15-Steroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
AT233177B (de) Verfahren zur Herstellung des neuen 6α-Methyl-17 α-hydroxyprogesterons und seiner Ester
AT275054B (de) Verfahren zur Herstellung von neuen 9β,10α-Steroiden
DE1493145C (de) In 4-Stellung unsubstituierte 3-Hydroxy-1,5-bisdehydro-steroide der Androstanreihe